{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:30:57Z","timestamp":1792650657215,"version":"4.5.0"},"reference-count":202,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Candida albicans is an opportunistic yeast and the major human fungal pathogen in the USA, as well as in many other regions of the world. Infections with C. albicans can range from superficial mucosal and dermatological infections to life-threatening infections of the bloodstream and vital organs. The azole antifungals remain an important mainstay treatment of candidiasis and therefore the investigation and understanding of the evolution, frequency and mechanisms of azole resistance are vital to improving treatment strategies against this organism. Here the organism C. albicans and the genetic changes and molecular bases underlying the currently known resistance mechanisms to the azole antifungal class are reviewed, including up-regulated expression of efflux pumps, changes in the expression and amino acid composition of the azole target Erg11 and alterations to the organism\u2019s typical sterol biosynthesis pathways. Additionally, we update what is known about activating mutations in the zinc cluster transcription factor (ZCF) genes regulating many of these resistance mechanisms and review azole import as a potential contributor to azole resistance. Lastly, investigations of azole tolerance in C. albicans and its implicated clinical significance are reviewed.<\/jats:p>","DOI":"10.1093\/jac\/dkz400","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:26:39Z","timestamp":1567625199000},"page":"257-270","source":"Crossref","is-referenced-by-count":108,"title":["Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus<i>Candida albicans<\/i>"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-4656","authenticated-orcid":false,"given":"Andrew T","family":"Nishimoto","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3216-263X","authenticated-orcid":false,"given":"Cheshta","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P David","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"2021061512512767100_dkz400-B1","doi-asserted-by":"crossref","first-page":"e66019.","DOI":"10.1371\/journal.pone.0066019","article-title":"Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"key":"2021061512512767100_dkz400-B2","doi-asserted-by":"crossref","first-page":"e1000713.","DOI":"10.1371\/journal.ppat.1000713","article-title":"Characterization of the oral fungal microbiome (mycobiome) in healthy individuals","volume":"6","author":"Ghannoum","year":"2010","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12171","article-title":"Topographic diversity of fungal and bacterial communities in human skin","volume":"498","author":"Findley","year":"2013","journal-title":"Nature"},{"key":"2021061512512767100_dkz400-B4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/aid.2012.0269","article-title":"Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women","volume":"29","author":"Merenstein","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2021061512512767100_dkz400-B5","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216 Suppl 3","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"2021061512512767100_dkz400-B6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2021061512512767100_dkz400-B7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","article-title":"Multidrug-resistant Candida auris: \u2018new kid on the block\u2019 in hospital-associated infections?","volume":"94","author":"Chowdhary","year":"2016","journal-title":"J Hosp Infect"},{"key":"2021061512512767100_dkz400-B8","doi-asserted-by":"crossref","first-page":"R287.","DOI":"10.1186\/cc10574","article-title":"Risk factors for invasive fungal disease in critically ill adult patients: a systematic review","volume":"15","author":"Muskett","year":"2011","journal-title":"Crit Care"},{"key":"2021061512512767100_dkz400-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","article-title":"The changing epidemiology of healthcare-associated candidemia over three decades","volume":"73","author":"Diekema","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B11","first-page":"183","article-title":"Epidemiology of opportunistic invasive mycoses","volume":"7","author":"Kullberg","year":"2002","journal-title":"Eur J Med Res"},{"key":"2021061512512767100_dkz400-B12","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"key":"2021061512512767100_dkz400-B13","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73 Suppl 1","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"2021061512512767100_dkz400-B16","first-page":"2173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2016","journal-title":"Front Microbiol"},{"key":"2021061512512767100_dkz400-B17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: epidemiology, microbiology and risk factors","volume":"42","author":"Goncalves","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"2021061512512767100_dkz400-B19","doi-asserted-by":"crossref","first-page":"18026.","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2021061512512767100_dkz400-B20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2021061512512767100_dkz400-B21","first-page":"155","article-title":"Risk factors for candidemia-related mortality at a medical center in central Taiwan","volume":"39","author":"Cheng","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"2021061512512767100_dkz400-B22","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1439-0507.2003.00883.x","article-title":"An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit","volume":"46","author":"Chowdhary","year":"2003","journal-title":"Mycoses"},{"key":"2021061512512767100_dkz400-B24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1099\/jmm.0.048785-0","article-title":"Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility","volume":"62","author":"Farooqi","year":"2013","journal-title":"J Med Microbiol"},{"key":"2021061512512767100_dkz400-B25","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"2021061512512767100_dkz400-B26","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"2021061512512767100_dkz400-B27","doi-asserted-by":"crossref","first-page":"e1006290.","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans biofilms and human disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"2021061512512767100_dkz400-B29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2021061512512767100_dkz400-B30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2015.04.008","article-title":"Isavuconazole, micafungin, and 8 comparator antifungal agents\u2019 susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values","volume":"82","author":"Pfaller","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0255-0857.158569","article-title":"Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital","volume":"33","author":"Ying","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"2021061512512767100_dkz400-B33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B34","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/JCM.43.6.2729-2735.2005","article-title":"Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit","volume":"43","author":"Sarvikivi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B35","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1128\/AAC.00466-11","article-title":"Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia","volume":"55","author":"Canton","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/myc.12206","article-title":"Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011","volume":"57","author":"Pfaller","year":"2014","journal-title":"Mycoses"},{"key":"2021061512512767100_dkz400-B37","doi-asserted-by":"crossref","first-page":"e0213532.","DOI":"10.1371\/journal.pone.0213532","article-title":"Candida lusitaniae in Kuwait: prevalence, antifungal susceptibility and role in neonatal fungemia","volume":"14","author":"Khan","year":"2019","journal-title":"PLoS One"},{"key":"2021061512512767100_dkz400-B38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/515006","article-title":"Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients","volume":"27","author":"Martins","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/515554","article-title":"Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients","volume":"25","author":"Martins","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"key":"2021061512512767100_dkz400-B41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2021061512512767100_dkz400-B42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s100960000323","article-title":"Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients","volume":"19","author":"Masia Canuto","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/JCM.02363-09","article-title":"Antifungal susceptibility testing of Candida isolates from the Candida Surveillance Study","volume":"48","author":"Lyon","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","article-title":"Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B46","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B47","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B48","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.02615-13","article-title":"Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole","volume":"58","author":"Espinel-Ingroff","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B49","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0006-291X(89)91792-0","article-title":"Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals","volume":"164","author":"Watson","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2021061512512767100_dkz400-B50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0014-5793(96)01360-9","article-title":"Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol \u03945,6-desaturation","volume":"400","author":"Kelly","year":"1997","journal-title":"FEBS Letters"},{"key":"2021061512512767100_dkz400-B51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2021061512512767100_dkz400-B52","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","article-title":"Isavuconazole: a review in invasive aspergillosis and mucormycosis","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"key":"2021061512512767100_dkz400-B53","doi-asserted-by":"crossref","first-page":"e01315","DOI":"10.1128\/AAC.01315-18","article-title":"In vivo efficacy of VT-1129 against experimental cryptococcal meningitis with the use of a loading dose-maintenance dose administration strategy","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B54","doi-asserted-by":"crossref","first-page":"e00341-19","DOI":"10.1128\/AAC.00341-19","article-title":"In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B55","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1128\/AAC.00593-15","article-title":"Evaluation of VT-1161 for treatment of coccidioidomycosis in murine infection models","volume":"59","author":"Shubitz","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B56","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/AAC.02770-15","article-title":"The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against Cryptococcus neoformans and Cryptococcus gattii","volume":"60","author":"Lockhart","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B57","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/AAC.00185-15","article-title":"Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis","volume":"59","author":"Garvey","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B58","doi-asserted-by":"crossref","first-page":"e02233-18","DOI":"10.1128\/AAC.02233-18","article-title":"The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B59","article-title":"Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161","author":"Nishimoto","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B60","year":"2018"},{"key":"2021061512512767100_dkz400-B61","year":"2012"},{"key":"2021061512512767100_dkz400-B62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(78)90403-8","article-title":"Miconazole-resistant Candida","volume":"1","author":"Holt","year":"1978","journal-title":"Lancet"},{"key":"2021061512512767100_dkz400-B63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF01641320","article-title":"Clinical isolates of Candida albicans","volume":"7","author":"Holt","year":"1979","journal-title":"Infection"},{"key":"2021061512512767100_dkz400-B64","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B65","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B67","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2021061512512767100_dkz400-B68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: a multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B69","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidaemia surveillance: results from a Norwegian national study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2021061512512767100_dkz400-B70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"2021061512512767100_dkz400-B71","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B72","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021061512512767100_dkz400-B73","first-page":"21","article-title":"Oral manifestations of HIV disease: a review","volume":"17","author":"Askinyte","year":"2015","journal-title":"Stomatologija"},{"key":"2021061512512767100_dkz400-B74","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1128\/JCM.37.12.3896-3900.1999","article-title":"Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer","volume":"37","author":"Redding","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00352101","article-title":"Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals","volume":"27","author":"Prasad","year":"1995","journal-title":"Curr Genet"},{"key":"2021061512512767100_dkz400-B76","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","article-title":"Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene","volume":"143","author":"Sanglard","year":"1997","journal-title":"Microbiology"},{"key":"2021061512512767100_dkz400-B77","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B78","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B79","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jac\/dkh456","article-title":"Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance","volume":"54","author":"Niimi","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B80","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B81","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"2021061512512767100_dkz400-B82","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.01106-07","article-title":"Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans","volume":"52","author":"Manoharlal","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1099\/mic.0.035154-0","article-title":"PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans","volume":"156","author":"Manoharlal","year":"2010","journal-title":"Microbiology (Reading, Engl)"},{"key":"2021061512512767100_dkz400-B84","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/AAC.00926-08","article-title":"Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance","volume":"53","author":"Tsao","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B85","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkq354","article-title":"Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients","volume":"65","author":"Siikala","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B86","doi-asserted-by":"crossref","first-page":"e25623.","DOI":"10.1371\/journal.pone.0025623","article-title":"The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans","volume":"6","author":"Sasse","year":"2011","journal-title":"PLoS One"},{"key":"2021061512512767100_dkz400-B87","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B88","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1365-2958.2002.02814.x","article-title":"A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance","volume":"43","author":"de Micheli","year":"2002","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0061(19980430)14:6<517::AID-YEA250>3.0.CO;2-D","article-title":"Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals","volume":"14","author":"Hernaez","year":"1998","journal-title":"Yeast"},{"key":"2021061512512767100_dkz400-B90","doi-asserted-by":"crossref","first-page":"e01342","DOI":"10.1128\/AAC.01342-17","article-title":"Mediator tail module is required for Tac1-activated CDR1 expression and azole resistance in Candida albicans","volume":"61","author":"Liu","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B91","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/EC.00137-15","article-title":"The ABCs of Candida albicans multidrug transporter Cdr1","volume":"14","author":"Prasad","year":"2015","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B92","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/EC.00327-07","article-title":"Genome-wide expression and location analyses of the Candida albicans Tac1p regulon","volume":"6","author":"Liu","year":"2007","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B93","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.02157-15","article-title":"Activity of isavuconazole and other azoles against Candida clinical isolates and yeast model systems with known azole resistance mechanisms","volume":"60","author":"Sanglard","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B94","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14\u03b1-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B95","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.00182-07","article-title":"A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole","volume":"51","author":"Cheng","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B96","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00259685","article-title":"Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate","volume":"227","author":"Fling","year":"1991","journal-title":"Mol Gen Genet"},{"key":"2021061512512767100_dkz400-B97","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.38.4.648","article-title":"Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene","volume":"38","author":"Ben-Yaacov","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B98","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","article-title":"Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains","volume":"42","author":"Franz","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B99","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.42.11.2932","article-title":"Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis","volume":"42","author":"Lopez-Ribot","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B100","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1365-2958.2000.01899.x","article-title":"Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates","volume":"36","author":"Wirsching","year":"2000","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/JB.182.2.400-404.2000","article-title":"Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor","volume":"182","author":"Wirsching","year":"2000","journal-title":"J Bacteriol"},{"key":"2021061512512767100_dkz400-B102","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/AAC.49.7.2785-2792.2005","article-title":"Drug-induced regulation of the MDR1 promoter in Candida albicans","volume":"49","author":"Harry","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B103","doi-asserted-by":"crossref","first-page":"e164.","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschhauser","year":"2007","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","article-title":"Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains","volume":"69","author":"Dunkel","year":"2008","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","article-title":"Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism","volume":"3","author":"Silver","year":"2004","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B106","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","article-title":"Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients","volume":"45","author":"Perea","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B107","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","article-title":"Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes","volume":"49","author":"MacPherson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B108","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/EC.00331-06","article-title":"cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p","volume":"6","author":"Oliver","year":"2007","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B109","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/EC.00070-08","article-title":"Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance","volume":"7","author":"Znaidi","year":"2008","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B111","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.01343-10","article-title":"Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans","volume":"55","author":"Schubert","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B113","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.00995-10","article-title":"An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans","volume":"55","author":"Hoot","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B114","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/EC.00215-12","article-title":"Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans","volume":"11","author":"Flowers","year":"2012","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B115","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/EC.00221-13","article-title":"UPC2 is universally essential for azole antifungal resistance in Candida albicans","volume":"13","author":"Vasicek","year":"2014","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B116","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/mmi.12327","article-title":"Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation","volume":"89","author":"Schillig","year":"2013","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B117","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/mmy\/myv002","article-title":"Trisomy of chromosome R confers resistance to triazoles in Candida albicans","volume":"53","author":"Li","year":"2015","journal-title":"Med Mycol"},{"key":"2021061512512767100_dkz400-B118","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.1128\/AAC.00078-19","article-title":"The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B120","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.41.7.1488","article-title":"The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.42.2.241","article-title":"Amino acid substitutions in the cytochrome P-450 lanosterol 14\u03b1-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents","volume":"42","author":"Sanglard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B122","first-page":"171","article-title":"Y132H substitution in Candida albicans sterol 14\u03b1-demethylase confers fluconazole resistance by preventing binding to haem","volume":"180","author":"Kelly","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"2021061512512767100_dkz400-B123","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1999.1136","article-title":"The G464S amino acid substitution in Candida albicans sterol 14\u03b1-demethylase causes fluconazole resistance in the clinic through reduced affinity","volume":"262","author":"Kelly","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2021061512512767100_dkz400-B124","first-page":"1390","article-title":"Analysis of ERG11 gene mutation in Candida albicans","volume":"25","author":"Wang","year":"2005","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"2021061512512767100_dkz400-B125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jac\/dkn015","article-title":"Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations","volume":"61","author":"Xu","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B126","doi-asserted-by":"crossref","first-page":"167.","DOI":"10.1186\/1471-2180-9-167","article-title":"Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Microbiol"},{"key":"2021061512512767100_dkz400-B127","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.007","article-title":"Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene","volume":"123","author":"Feng","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"2021061512512767100_dkz400-B128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12223-010-0045-2","article-title":"Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing","volume":"55","author":"Kim","year":"2010","journal-title":"Folia Microbiol (Praha)"},{"key":"2021061512512767100_dkz400-B129","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14\u03b1-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.riam.2013.01.001","article-title":"The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance","volume":"30","author":"Oliveira Carvalho","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"2021061512512767100_dkz400-B132","doi-asserted-by":"crossref","first-page":"547","DOI":"10.18388\/abp.2013_2019","article-title":"Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates","volume":"60","author":"Strzelczyk","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"2021061512512767100_dkz400-B133","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1567-1364.12042","article-title":"Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans","volume":"13","author":"Xiang","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"2021061512512767100_dkz400-B134","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/mdr.2012.0204","article-title":"In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations","volume":"19","author":"Ying","year":"2013","journal-title":"Microb Drug Resist"},{"key":"2021061512512767100_dkz400-B135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diagmicrobio.2013.08.018","article-title":"Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene","volume":"77","author":"Zhang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B136","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/myc.12027","article-title":"Association of T916C (Y257H) mutation in Candida albicans ERG11 with fluconazole resistance","volume":"56","author":"Zhao","year":"2013","journal-title":"Mycoses"},{"key":"2021061512512767100_dkz400-B137","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mycmed.2014.04.001","article-title":"Is the S405F mutation in Candida albicans ERG11 gene sufficient to confer resistance to fluconazole?","volume":"24","author":"Oliveira-Carvalho","year":"2014","journal-title":"J Mycol Med"},{"key":"2021061512512767100_dkz400-B138","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B139","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J Biol Chem"},{"key":"2021061512512767100_dkz400-B140","doi-asserted-by":"crossref","first-page":"e01134-18","DOI":"10.1128\/AAC.01134-18","article-title":"Crystal structures of full-length lanosterol 14\u03b1-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery","volume":"62","author":"Keniya","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B141","doi-asserted-by":"crossref","first-page":"e02586","DOI":"10.1128\/AAC.02586-18","article-title":"The evolution of azole resistance in Candida albicans sterol 14\u03b1-demethylase (CYP51) through incremental amino acid substitutions","volume":"63","author":"Warrilow","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B142","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-1119(99)00263-2","article-title":"Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans","volume":"236","author":"Miyazaki","year":"1999","journal-title":"Gene"},{"key":"2021061512512767100_dkz400-B144","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2672.1990.tb01564.x","article-title":"A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains","volume":"69","author":"Howell","year":"1990","journal-title":"J Appl Bacteriol"},{"key":"2021061512512767100_dkz400-B145","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jac\/dks186","article-title":"Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence","volume":"67","author":"Morio","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B146","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.50.2.580-586.2006","article-title":"Fluconazole treatment is effective against a Candida albicans erg3\/erg3 mutant in vivo despite in vitro resistance","volume":"50","author":"Miyazaki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B147","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1128\/AAC.05720-11","article-title":"Azole resistance by loss of function of the sterol \u03945,6-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence","volume":"56","author":"Vale-Silva","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B148","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1128\/AAC.49.9.3646-3651.2005","article-title":"Inactivation of sterol \u03945,6-desaturase attenuates virulence in Candida albicans","volume":"49","author":"Chau","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B149","doi-asserted-by":"crossref","first-page":"e00225","DOI":"10.1128\/mBio.00225-18","article-title":"Loss of Upc2p-inducible ERG3 transcription is sufficient to confer niche-specific azole resistance without compromising Candida albicans pathogenicity","volume":"9","author":"Luna-Tapia","year":"2018","journal-title":"MBio"},{"key":"2021061512512767100_dkz400-B150","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1128\/JB.181.13.4041-4049.1999","article-title":"Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans","volume":"181","author":"Perepnikhatka","year":"1999","journal-title":"J Bacteriol"},{"key":"2021061512512767100_dkz400-B151","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2958.2003.03852.x","article-title":"Chromosome 1 trisomy compromises the virulence of Candida albicans","volume":"51","author":"Chen","year":"2004","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B152","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/JB.182.6.1515-1522.2000","article-title":"Evolution of drug resistance in experimental populations of Candida albicans","volume":"182","author":"Cowen","year":"2000","journal-title":"J Bacteriol"},{"key":"2021061512512767100_dkz400-B153","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/EC.4.1.156-165.2005","article-title":"Demonstration of loss of heterozygosity by single-nucleotide polymorphism microarray analysis and alterations in strain morphology in Candida albicans strains during infection","volume":"4","author":"Forche","year":"2005","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B154","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1365-2958.2005.04492.x","article-title":"Comparative genome hybridization reveals widespread aneuploidy in Candida albicans laboratory strains","volume":"55","author":"Selmecki","year":"2005","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"2021061512512767100_dkz400-B156","doi-asserted-by":"crossref","first-page":"e00662.","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of Candida albicans","volume":"4","author":"Ford","year":"2015","journal-title":"Elife"},{"key":"2021061512512767100_dkz400-B157","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2958.2004.04068.x","article-title":"Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation","volume":"52","author":"Legrand","year":"2004","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B158","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1534\/genetics.115.178020","article-title":"Parasexual ploidy reduction drives population heterogeneity through random and transient aneuploidy in Candida albicans","volume":"200","author":"Hickman","year":"2015","journal-title":"Genetics"},{"key":"2021061512512767100_dkz400-B159","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1099\/mic.0.000478","article-title":"A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans","volume":"163","author":"Anderson","year":"2017","journal-title":"Microbiology"},{"key":"2021061512512767100_dkz400-B160","doi-asserted-by":"crossref","first-page":"e1001126.","DOI":"10.1371\/journal.ppat.1001126","article-title":"Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi","volume":"6","author":"Mansfield","year":"2010","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B161","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/AAC.05003-14","article-title":"Azole drug import into the pathogenic fungus Aspergillus fumigatus","volume":"59","author":"Esquivel","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B162","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrmicro1835","article-title":"The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype","volume":"6","author":"Cowen","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"2021061512512767100_dkz400-B163","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1128\/EC.00274-06","article-title":"Genetic architecture of Hsp90-dependent drug resistance","volume":"5","author":"Cowen","year":"2006","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B164","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"2021061512512767100_dkz400-B165","doi-asserted-by":"crossref","first-page":"e1000532.","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B166","doi-asserted-by":"crossref","first-page":"e1001069.","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B167","doi-asserted-by":"crossref","first-page":"e1000471.","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"Cowen","year":"2009","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B168","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","article-title":"Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence","volume":"48","author":"Sanglard","year":"2003","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B169","doi-asserted-by":"crossref","first-page":"e01785","DOI":"10.1128\/AAC.01785-17","article-title":"The Rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets, including Hsp90 and Ipt1","volume":"62","author":"Garnaud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B170","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/AAC.48.9.3358-3366.2004","article-title":"Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole","volume":"48","author":"Mateus","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B171","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","article-title":"Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols","volume":"71","author":"Mukherjee","year":"2003","journal-title":"Infect Immun"},{"key":"2021061512512767100_dkz400-B172","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/599838","article-title":"Time course global gene expression analysis of an in vivo Candida biofilm","volume":"200","author":"Nett","year":"2009","journal-title":"J Infect Dis"},{"key":"2021061512512767100_dkz400-B173","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","author":"Nobile","year":"2012","journal-title":"Cell"},{"key":"2021061512512767100_dkz400-B174","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkf049","article-title":"Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms","volume":"49","author":"Ramage","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1099\/jmm.0.46569-0","article-title":"Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance","volume":"55","author":"Al-Fattani","year":"2006","journal-title":"J Med Microbiol"},{"key":"2021061512512767100_dkz400-B176","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/46.3.397","article-title":"Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents","volume":"46","author":"Baillie","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B177","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/AAC.01056-06","article-title":"Putative role of \u03b2-1,3 glucans in Candida albicans biofilm resistance","volume":"51","author":"Nett","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B178","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1086\/651200","article-title":"Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan","volume":"202","author":"Nett","year":"2010","journal-title":"J Infect Dis"},{"key":"2021061512512767100_dkz400-B179","doi-asserted-by":"crossref","first-page":"e1002848.","DOI":"10.1371\/journal.ppat.1002848","article-title":"A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance","volume":"8","author":"Taff","year":"2012","journal-title":"PLoS Pathog"},{"key":"2021061512512767100_dkz400-B180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021061512512767100_dkz400-B181","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B182","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13469","article-title":"Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations","volume":"513","author":"Fridman","year":"2014","journal-title":"Nature"},{"key":"2021061512512767100_dkz400-B183","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"2021061512512767100_dkz400-B184","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"key":"2021061512512767100_dkz400-B185","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B186","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","article-title":"Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B187","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/dkh040","article-title":"Drug resistance genes and trailing growth in Candida albicans isolates","volume":"53","author":"Lee","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2021061512512767100_dkz400-B188","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/AAC.00732-16","article-title":"The RTA3 gene, encoding a putative lipid translocase, influences the susceptibility of Candida albicans to fluconazole","volume":"60","author":"Whaley","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B189","doi-asserted-by":"crossref","first-page":"e01337-18","DOI":"10.1128\/AAC.01337-18","article-title":"Loss of C-5 sterol desaturase activity in Candida albicans: azole resistance or merely trailing growth?","volume":"63","author":"Luna-Tapia","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B190","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing end point phenotype in antifungal susceptibility testing is pH dependent","volume":"43","author":"Marr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B191","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/JCM.36.1.153-156.1998","article-title":"Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method","volume":"36","author":"Revankar","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2021061512512767100_dkz400-B192","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.42.1.129","article-title":"Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis","volume":"42","author":"Rex","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B193","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B194","doi-asserted-by":"crossref","first-page":"2470.","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat Commun"},{"key":"2021061512512767100_dkz400-B195","doi-asserted-by":"crossref","first-page":"4495.","DOI":"10.1038\/s41467-018-06944-1","article-title":"Candida albicans gains azole resistance by altering sphingolipid composition","volume":"9","author":"Gao","year":"2018","journal-title":"Nat Commun"},{"key":"2021061512512767100_dkz400-B196","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/EC.05100-11","article-title":"Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1","volume":"10","author":"Schubert","year":"2011","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B197","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/AAC.04448-14","article-title":"Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors","volume":"59","author":"Schneider","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B198","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2958.2007.05931.x","article-title":"The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans","volume":"66","author":"Znaidi","year":"2007","journal-title":"Mol Microbiol"},{"key":"2021061512512767100_dkz400-B199","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","article-title":"Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system","volume":"8","author":"Coste","year":"2009","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B200","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.00555-13","article-title":"Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals","volume":"57","author":"Eddouzi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021061512512767100_dkz400-B201","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/EC.00245-13","article-title":"Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence","volume":"13","author":"Lohberger","year":"2014","journal-title":"Eukaryot Cell"},{"key":"2021061512512767100_dkz400-B202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijantimicag.2013.07.013","article-title":"Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans","volume":"42","author":"Morio","year":"2013","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/2\/257\/38646399\/jac_75_2_257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/2\/257\/38646399\/jac_75_2_257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T23:44:18Z","timestamp":1721691858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/2\/257\/5585656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":202,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,10,11]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz400","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,10,11]]}}}